Shiela M Strauss

Faculty

Shiela Strauss headshot

Shiela M Strauss

Associate Professor

1 212 998 5280

433 FIRST AVENUE
NEW YORK, NY 10010
United States

Shiela M Strauss's additional information

A Principal Investigator since 1999 on grants funded by NIH and private foundations, Dr. Strauss’ research has primarily focused on studying the drug treatment response to the hepatitis C virus, and support for alcohol reduction among HIV positive patients. Dr. Strauss has also applied innovative statistical methodology to examine the validity of self-report of HIV status among out-of-treatment drug users. A more recent focus has involved an examination of the relationship between periodontal disease and diabetes, and the potential of the dental office to serve as a site for diabetes screening.

PhD, 1996, Graduate School and University Center of the City University of New York;
MA, 1972, Lehman College of the City University of New York;
BS, 1967, City College of the City University of New York

Women's health
Oral-systemic health
Non-communicable disease
Infectious disease

Jewish Diabetes Association;
Phi Beta Kappa

Faculty Honors Awards

Fulbright Senior Specialist Award: Bringing the hepatitis C research to Israel and the Middle East; (2005)
1996, Dissertation Year Fellowship Award: Graduate School and University Center of the City University of New York; (1996)
Edyth May Sliffe Award for Distinguished High School Mathematics Teaching, Mathematics Association of America; (1989)
Presidential Scholars Program Certificate of Excellence, The White House; (1988)
Election to Phi Beta Kappa (1966)

Publications

Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients

Kumar, P. C., Cleland, C. M., Gourevitch, M. N., Rotrosen, J., Strauss, S., Russell, L., & McNeely, J. (2016). Drug and Alcohol Dependence, 165, 38-44. 10.1016/j.drugalcdep.2016.05.030
Abstract
Abstract
Background An Audio Computer-assisted Self Interview (ACASI) version of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) could reduce barriers to substance use screening and assessment in primary care settings. This study evaluated the diagnostic accuracy of an ACASI ASSIST for identification of unhealthy substance use and substance use disorders (SUD). Methods 399 adult patients were consecutively recruited from an urban safety-net primary care clinic. ACASI ASSIST scores for tobacco, alcohol, marijuana, and cocaine were compared against reference standard measures to assess the instrument's diagnostic accuracy for identifying unhealthy use and SUD, first using empirically-derived optimal cutoffs, and second using the currently recommended ASSIST cutoffs. Results For identifying any unhealthy use, at the empirically-derived cutoffs the ACASI ASSIST had 93.6% sensitivity and 85.8% specificity (AUC = 0.90) for tobacco, 85.9% sensitivity and 60.3% specificity (AUC = 0.73), for alcohol in men, 100% sensitivity and 62.4% specificity (AUC = 0.81) for alcohol in women, 94.6% sensitivity and 81.6% specificity (AUC = 0.88) for marijuana, and 86.1% sensitivity, 84.0% specificity (AUC = 0.85) for cocaine. For SUD, sensitivity ranged from 79% (for alcohol in males), to 100% (for tobacco), and specificity was 83% or higher (AUCs ranged 0.83–0.91). For substances other than tobacco, empirically-derived cutoff scores were lower than the standard cutoffs, and resulted in higher sensitivity and lower specificity for identifying unhealthy substance use. Conclusions The ACASI ASSIST is a valid measure of unhealthy use and SUD for substances that are commonly used by primary care patients, and could facilitate effective and efficient screening for substance use in medical settings.

Alcohol misuse, risky sexual behaviors, and HIV or syphilis infections among Chinese men who have sex with men

Liu, Y., Ruan, Y., Strauss, S. M., Yin, L., Liu, H., Amico, K. R., Zhang, C., Shao, Y., Qian, H. Z., & Vermund, S. H. (2016). Drug and Alcohol Dependence, 168, 239-246. 10.1016/j.drugalcdep.2016.09.020
Abstract
Abstract
Background Few studies have employed standardized alcohol misuse measures to assess relationships with sexual risk and HIV/syphilis infections among Chinese men who have sex with men (MSM). Methods We conducted a cross-sectional study among MSM in Beijing during 2013–2014. An interviewer-administered survey was conducted to collect data on sociodemographics, high-risk behaviors, and alcohol use/misuse patterns (hazardous/binge drinking and risk of alcohol dependence) in the past 3 months using Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). We defined AUDIT-C score ≥4 as recent hazardous drinkers, and drinking ≥6 standard drinks on one occasion as recent binge drinkers. Results Of 3588 participants, 14.4% reported hazardous drinking, 16.8% reported binge drinking. Hazardous and binge drinking are both associated with these factors (p < 0.05): older age, being migrants, living longer in Beijing, township/village origin, being employed, higher income, self-perceived low/no HIV risk, and sex-finding via non-Internet venues. Hazardous (vs non-hazardous) or binge (vs. non-binge) drinkers were more likely to use illicit drugs, use alcohol before sex, have multiple partnerships, pay for sex, and have condomless insertive anal intercourse. MSM who reported binge (AOR, 1.34, 95% CI, 1.02–1.77) or hazardous (AOR, 1.36, 95% CI, 1.02–1.82) drinking were more likely to be HIV-infected. MSM at high risk of current alcohol dependence (AUDIT-C ≥8) were more likely to be HIV- (AOR, 2.37, 95% CI, 1.39–4.04) or syphilis-infected (AOR, 1.96, 95% CI, 1.01–3.86). Conclusions Recent alcohol misuse was associated with increased sexual and HIV/syphilis risks among Chinese MSM, emphasizing the needs of implementing alcohol risk reduction programs in this population.

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: Study protocol for a hybrid design randomized controlled trial

Frimpong, J. A., D’Aunno, T., Perlman, D. C., Strauss, S. M., Mallow, A., Hernandez, D., Schackman, B. R., Feaster, D. J., & Metsch, L. R. (2016). Trials, 17(1). 10.1186/s13063-016-1225-4
Abstract
Abstract
Background: More than 1.2 million people in the United States are living with human immunodeficiency virus (HIV), and 3.2 million are living with hepatitis C virus (HCV). An estimated 25% of persons living with HIV also have HCV. It is therefore of great public health importance to ensure the prompt diagnosis of both HIV and HCV in populations that have the highest prevalence of both infections, including individuals with substance use disorders (SUD). Methods/design: In this theory-driven, efficacy-effectiveness-implementation hybrid study, we will develop and test an on-site bundled rapid HIV/HCV testing intervention for SUD treatment programs. Its aim is to increase the receipt of HIV and HCV test results among SUD treatment patients. Using a rigorous process involving patients, providers, and program managers, we will incorporate rapid HCV testing into evidence-based HIV testing and linkage to care interventions. We will then test, in a randomized controlled trial, the extent to which this bundled rapid HIV/HCV testing approach increases receipt of HIV and HCV test results. Lastly, we will conduct formative research to understand the barriers to, and facilitators of, the adoption, implementation, and sustainability of the bundled rapid testing strategy in SUD treatment programs. Discussion: Novel approaches that effectively integrate on-site rapid HIV and rapid HCV testing are needed to address both the HIV and HCV epidemics. If feasible and efficacious, bundled rapid HIV/HCV testing may offer a scalable, potentially cost-effective approach to testing high-risk populations, such as patients of SUD treatment programs. It may ultimately lead to improved linkage to care and progress through the HIV and HCV care and treatment cascades. Trial registration: ClinicalTrials.gov: NCT02355080.

The Oral Health Care Manager in a Patient-Centered Health Facility

Theile, C. W., Strauss, S. M., Northridge, M. E., & Birenz, S. (2016). Journal of Evidence-Based Dental Practice, 16, 34-42. 10.1016/j.jebdp.2016.01.026
Abstract
Abstract
The dental hygienist team member has an opportunity to coordinate care within an interprofessional practice as an oral health care manager. Background and purpose Although dental hygienists are currently practicing within interprofessional teams in settings such as pediatric offices, hospitals, nursing homes, schools, and federally qualified health centers, they often still assume traditional responsibilities rather than practicing to the full extent of their training and licenses. This article explains the opportunity for the dental hygiene professional to embrace patient-centered care as an oral health care manager who can facilitate integration of oral and primary care in a variety of health care settings. Methods Based on an innovative model of collaboration between a college of dentistry and a college of nursing, an idea emerged among several faculty members for a new management method for realizing continuity and coordination of comprehensive patient care. Involved faculty members began working on the development of an approach to interprofessional practice with the dental hygienist serving as an oral health care manager who would address both oral health care and a patient's related primary care issues through appropriate referrals and follow-up. This approach is explained in this article, along with the results of several pilot studies that begin to evaluate the feasibility of a dental hygienist as an oral health care manager. Conclusion A health care provider with management skills and leadership qualities is required to coordinate the interprofessional provision of comprehensive health care. The dental hygienist has the opportunity to lead closer integration of oral and primary care as an oral health care manager, by coordinating the team of providers needed to implement comprehensive, patient-centered care.

Predictors of Depression Among Adult Women With Diabetes in the United States: An Analysis Using National Health and Nutrition Examination Survey Data From 2007 to 2012

Strauss, S. M., Rosedale, M. T., & Rindskopf, D. M. (2016). Diabetes Educator, 42(6), 728-738. 10.1177/0145721716672339
Abstract
Abstract
Purpose: The purpose of the study was to identify the sex-specific characteristics that predict depression among adult women with diabetes. Methods: Data from the 2007-2012 National Health and Nutrition Examination Survey in the United States were used to identify the predictors of depression in a large sample of women ages 20 years and older with diabetes (n = 946). Results: When extrapolated to almost 9 million women in the United States ≥ 20 years of age with diabetes, 19.0% had depression. Female-specific significant predictors of depression included younger age (< 65 years old), less than high school graduation, self-rated fair or poor health, inactivity due to poor health, and pain that interferes with usual activities. Marital status and diabetes-related factors (years living with diabetes, use of insulin, parent or sibling with diabetes) were not significant predictors of depression in adult women with diabetes. Conclusion: When educating and counseling women with diabetes, diabetes educators should be aware that some of the predictors of depression in women with diabetes differ from those of populations that include both sexes. Depression screening, although important for all women with diabetes, should especially be performed among women with female-specific depression predictors.

Sexual Behaviors Linked to Drug and Alcohol Use Among Men Who Have Sex With Men in China

Zhang, C., Qian, H. Z., Yin, L., Liu, Y., Strauss, S. M., Ruan, Y., Shao, Y., Lu, H., & Vermund, S. H. (2016). Substance Use and Misuse, 51(14), 1821-1830. 10.1080/10826084.2016.1197264
Abstract
Abstract
Background: High-risk sexual behaviors drive the HIV epidemic among men who have sex with men (MSM). Alcohol consumption and use of club drugs may increase sexual risk behaviors. We evaluated effects of drug and alcohol use on sexual behaviors with both their male and female partners as well as on HIV and syphilis infections among MSM in China. Methods: As the part of a community randomized clinical trial that conducted among MSM in Beijing from 2013 to 2015, we recruited a total of 3,680 participants cross-sectionally. A self-administered questionnaire was employed to collect information regarding demographics, sexual behaviors, and a history of alcohol and drug use. Blood sample was collected for HIV and syphilis testing. Results: A total of 3,588 MSM completed the survey and were included in the data analysis. The mean age was 29.9 with 97.3% of Han-ethnicity and 85.0% unmarried. The HIV and syphilis prevalence was 12.7% and 7.4%, respectively. Drug use was significantly associated with higher odds of HIV infection (aOR = 1.3, 95% Confidence Interval [CI] = 1.0,1.6), but not associated with syphilis. A higher level of alcohol consumption was similarly associated with higher odds of HIV risks with both male (e.g., condomless sex acts) and female partners (e.g., numbers of sexual partners). Conclusion: The association between drug and alcohol use and high-risk behaviors is notable among MSM in China. Integrated HIV interventions that target substance use among MSM may be more effective than programs that only target HIV alone.

Validation of an audio computer-assisted self-interview (ACASI) version of the alcohol, smoking and substance involvement screening test (ASSIST) in primary care patients

McNeely, J., Strauss, S. M., Rotrosen, J., Ramautar, A., & Gourevitch, M. N. (2016). Addiction, 111(2), 233-244. 10.1111/add.13165
Abstract
Abstract
Background and Aims: To address barriers to implementing the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in medical settings, we adapted the traditional interviewer-administered (IA) ASSIST to an audio-guided computer assisted self-interview (ACASI) format. This study sought to validate the ACASI ASSIST by estimating the concordance, correlation and agreement of scores generated using the ACASI versus the reference standard IA ASSIST. Secondary aims were to assess feasibility and compare ASSIST self-report to drug testing results. Design: Participants completed the ACASI and IA ASSIST in a randomly assigned order, followed by drug testing. Setting: Urban safety-net primary care clinic in New York City, USA. Participants: A total of 393 adult patients. Measurements: Scores generated by the ACASI and IA ASSIST; drug testing results from saliva and hair samples. Findings: Concordance between the ACASI and IA ASSIST in identifying moderate-high-risk use was 92-99% for each substance class. Correlation was excellent for global scores [intraclass correlation (ICC)=0.937, confidence interval (CI)=0.924-0.948] and for substance-specific scores for tobacco (ICC=0.927, CI=0.912-0.940), alcohol (ICC=0.912, CI=0.893-0.927) and illicit drugs (ICC=0.854, CI=0.854-0.900) and good for prescription drugs (ICC=0.676, CI=0.613-0.729). Ninety-four per cent of differences in global scores fell within anticipated limits of agreement. Among participants with a positive saliva test, 74% self-reported use on the ACASI ASSIST. The ACASI ASSIST required a median time of 3.7minutes (range 0.7-15.4), and 21 (5.3%) participants requested assistance. Conclusions: The computer self-administered Alcohol, Smoking and Substance Involvement Screening Test appears to be a valid alternative to the interviewer-administered approach for identifying substance use in primary care patients.

Awareness of prediabetes and diabetes among persons with clinical depression

Rosedale, M., Strauss, S. M., Knight, C., & Malaspina, D. (2015). International Journal of Endocrinology, 2015. 10.1155/2015/839152
Abstract
Abstract
Background: Major depressive disorder (MDD) is highly comorbid with diabetes, a relationship underappreciated by clinicians. Purpose: Examine the proportion of nonpregnant individuals ≥20 years with MDD and elevated glucose and the demographic and clinical characteristics associated with unrecognized elevated glucose. Methods: 14,373 subjects who participated in the National Health and Nutrition Examination Survey (2007-2012) completed the PHQ-9 depression screen and had hemoglobin A1C (HbA1c) measured. PHQ-9 scores ≥10 and HbA1c scores ≥5.7% were defned as MDD and elevated HbA1c, respectively. Data were analyzed using complex survey sampling sofware. Results: 38.4% of the sample with MDD had elevated HbA1c readings. Compared with nondepressed subjects, they were significantly more likely to have elevated glucose readings (P = 0.003) and to be aware of their elevated glucose levels if they had a higher body mass index, family history of diabetes, more doctor visits in the past year, a usual care source, health insurance, or were taking hypertension or hypercholesterolemia medications. Conclusions: Many adults with MDD have elevated HbA1c levels, have never been advised of elevated HbA1c, have not received diabetes screening, and have minimal contact with a healthcare provider. Additional opportunities for diabetes risk screening in people with MDD are needed.

A brief patient self-administered substance use screening tool for primary care: Two-site validation study of the substance use brief screen (SUBS)

McNeely, J., Strauss, S. M., Saitz, R., Cleland, C. M., Palamar, J. J., Rotrosen, J., & Gourevitch, M. N. (2015). American Journal of Medicine, 128(7), 784.e9-784.e19. 10.1016/j.amjmed.2015.02.007
Abstract
Abstract
Background Substance use screening is widely encouraged in health care settings, but the lack of a screening approach that fits easily into clinical workflows has restricted its broad implementation. The Substance Use Brief Screen (SUBS) was developed as a brief, self-administered instrument to identify unhealthy use of tobacco, alcohol, illicit drugs, and prescription drugs. We evaluated the validity and test-retest reliability of the SUBS in adult primary care patients. Methods Adults aged 18-65 years were enrolled from urban safety net primary care clinics to self-administer the SUBS using touch-screen tablet computers for a test-retest reliability study (n = 54) and a 2-site validation study (n = 586). In the test-retest reliability study, the SUBS was administered twice within a 2-week period. In the validation study, the SUBS was compared with reference standard measures, including self-reported measures and oral fluid drug tests. We measured test-retest reliability and diagnostic accuracy of the SUBS for detection of unhealthy use and substance use disorder for tobacco, alcohol, and drugs (illicit and prescription drug misuse). Results Test-retest reliability was good or excellent for each substance class. For detection of unhealthy use, the SUBS had sensitivity and specificity of 97.8% (95% confidence interval [CI], 93.7-99.5) and 95.7% (95% CI, 92.4-97.8), respectively, for tobacco; and 85.2% (95% CI, 79.3-89.9) and 77.0% (95% CI, 72.6-81.1) for alcohol. For unhealthy use of illicit or prescription drugs, sensitivity was 82.5% (95% CI, 75.7-88.0) and specificity 91.1% (95% CI, 87.9-93.6). With respect to identifying a substance use disorder, the SUBS had sensitivity and specificity of 100.0% (95% CI, 92.7-100.0) and 72.1% (95% CI, 67.1-76.8) for tobacco; 93.5% (95% CI, 85.5-97.9) and 64.6% (95% CI, 60.2-68.7) for alcohol; and 85.7% (95% CI, 77.2-92.0) and 82.0% (95% CI, 78.2-85.3) for drugs. Analyses of area under the receiver operating curve (AUC) indicated good discrimination (AUC 0.74-0.97) for all substance classes. Assistance in completing the SUBS was requested by 11% of participants. Conclusions The SUBS was feasible for self-administration and generated valid results in a diverse primary care patient population. The 4-item SUBS can be recommended for primary care settings that are seeking to implement substance use screening.

Clinicians’ panel management self-efficacy to support their patients’ smoking cessation and hypertension control needs

Strauss, S. M., Jensen, A. E., Bennett, K., Skursky, N., Sherman, S. E., & Schwartz, M. D. (2015). Translational Behavioral Medicine, 5(1), 68-76. 10.1007/s13142-014-0287-7
Abstract
Abstract
Panel management, a set of tools and processes for proactively caring for patient populations, has potential to reduce morbidity and improve outcomes between office visits. We examined primary care staff’s self-efficacy in implementing panel management, its correlates, and an intervention’s impact on this self-efficacy. Primary care teams at two Veterans Health Administration (VA) hospitals were assigned to control or intervention conditions. Staff were surveyed at baseline and post-intervention, with a random subset interviewed post-intervention. Panel management self-efficacy was higher among staff participating in the panel management intervention. Self-efficacy was significantly correlated with sufficient training, aspects of team member interaction, and frequency of panel management use. Panel management self-efficacy was modest among primary care staff at two VA hospitals. Team level interventions may improve primary care staff’s confidence in practicing panel management, with this greater confidence related to greater team involvement with, and use of panel management.